The Effects of Ethyl-Alpha-Guanido-Methyl Ethanoate on Skin Reactions From Glatiramer Acetate Injections
- Conditions
- Multiple Sclerosis
- Interventions
- Drug: 1% Steroid CreamDrug: topical placebo cream with no active ingredientsDrug: AGEE cream
- Registration Number
- NCT00988988
- Lead Sponsor
- University of Nebraska
- Brief Summary
Participants with multiple sclerosis that are currently treated with glatiramer acetate (GA, Copaxone®) injections and have redness, pain, swelling, itching or a lump at the injection site will be recruited to examine histamine response of three topical treatments to reduce these symptoms.
- Detailed Description
Participants are asked to be in this study because they have multiple sclerosis, are currently treated with glatiramer acetate (GA, Copaxone®) injections and have redness, pain, swelling, itching or a lump at the injection site.
The purpose of this study is to determine if the use of ethyl-a-guanida-methyl ethanoate (AGEE) will decrease histamine response measured by redness, swelling, and itch response following subcutaneous injection of glatiramer acetate (GA) for the treatment of Multiple Sclerosis (MS).
Recruitment & Eligibility
- Status
- WITHDRAWN
- Sex
- All
- Target Recruitment
- Not specified
- Able to give informed consent
- Between ages 19-65
- Laboratory supported diagnosis of multiple sclerosis
- Currently treated with injectable GA, experiencing wheal and flare after injection
- Unable to give informed consent
- Treated with any other therapy for Multiple Sclerosis
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Steroid Cream 1% Steroid Cream 1% steroid cream placebo topical placebo cream with no active ingredients inactive cream AGEE cream AGEE cream AGEE cream is a creatine ethyl ester based product (an amino acid) that can be purchased over-the-counter without a prescription and is not FDA controlled
- Primary Outcome Measures
Name Time Method Histamine response after ethyl-α-guanida-methyl ethanoate (AGEE) and subcutaneous injection of glatiramer acetate Three weeks To determine if the use of ethyl-α-guanida-methyl ethanoate (AGEE) will decrease histamine response measured by wheal, flare and itch response following subcutaneous injection of glatiramer acetate for the treatment of Multiple Sclerosis
- Secondary Outcome Measures
Name Time Method